SARS-CoV-2 Spike Protéines
(SARS-CoV-2 Spike (SARS-CoV-2 S))
mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, RBD, V483A) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | Human Cells |
|
2.706,60 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (A352S, AA 319-541, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (A344S, AA 319-541, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (A348S, AA 319-541, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (A372T, AA 319-541, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (A372S, AA 319-541, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 14-307, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
323,60 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, E406Q, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, RBD) (rFc Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, D364Y, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
359,60 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, E471Q, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, F377L, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, F456E, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, RBD) (rFc Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, F338L, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, F342L, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
962,00 €
Voir le prix
|
|
| SARS-CoV-2 Spike Protein (SARS-CoV-2 S) (AA 319-541, F342L, RBD) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
359,60 €
Voir le prix
|
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- Human Cells
- Type Proteine
- Recombinant
Protein
- ELISA (ELISA: Application indiquée)
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 95 % as determined by reducing SDS-PAGE.
- Activité biologique
- Active
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 80 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 85 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 90 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 85 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 95 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 95 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 90 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 90 % as determined by reducing SDS-PAGE.
Protein
- ELISA (ELISA: Application indiquée)
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 95 % as determined by reducing SDS-PAGE.
- Activité biologique
- Active
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 90 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 85 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 80 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 90 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 90 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 90 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 95 % as determined by reducing SDS-PAGE.
Protein
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 95 % as determined by reducing SDS-PAGE.
Protein
- ELISA (ELISA: Application indiquée)
- Origine
- SARS Coronavirus-2 (SARS-CoV-2)
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- > 95 % as determined by reducing SDS-PAGE.
- Activité biologique
- Active
Dernières publications pour nos SARS-CoV-2 Spike Protéines
: "A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV." dans: Frontiers in immunology, Vol. 15, pp. 1473428, (2024) (PubMed).
: "Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells." dans: Vaccine, Vol. 42, Issue 6, pp. 1259-1267, (2024) (PubMed).
: "Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models." dans: Vaccines, Vol. 12, Issue 11, (2024) (PubMed).
: "A Naïve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern." dans: International journal of nanomedicine, Vol. 18, pp. 5781-5795, (2023) (PubMed).
: "Sensing Dynamically Evolved Short-Range Nanomechanical Forces in Fast-Mutating Single Viral Spike Proteins." dans: Small science, Vol. 3, Issue 8, pp. 2300029, (2023) (PubMed).
: "Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease." dans: Brain, behavior, and immunity, Vol. 109, pp. 251-268, (2023) (PubMed).
: "A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy." dans: PLoS pathogens, Vol. 19, Issue 1, pp. e1011085, (2023) (PubMed).
: "Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages." dans: Mucosal immunology, Vol. 15, Issue 3, pp. 515-524, (2022) (PubMed).
: "Nanoplasmonic biosensor for rapid detection of multiple viral variants in human serum." dans: Sensors and actuators. B, Chemical, Vol. 365, pp. 131906, (2022) (PubMed).
: "Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron." dans: Vaccines, Vol. 10, Issue 5, (2022) (PubMed).
: "Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells." dans: Vaccine, Vol. 42, Issue 6, pp. 1259-1267, (2024) (PubMed).
: "Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models." dans: Vaccines, Vol. 12, Issue 11, (2024) (PubMed).
: "A Naïve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern." dans: International journal of nanomedicine, Vol. 18, pp. 5781-5795, (2023) (PubMed).
: "Sensing Dynamically Evolved Short-Range Nanomechanical Forces in Fast-Mutating Single Viral Spike Proteins." dans: Small science, Vol. 3, Issue 8, pp. 2300029, (2023) (PubMed).
: "Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease." dans: Brain, behavior, and immunity, Vol. 109, pp. 251-268, (2023) (PubMed).
: "A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy." dans: PLoS pathogens, Vol. 19, Issue 1, pp. e1011085, (2023) (PubMed).
: "Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages." dans: Mucosal immunology, Vol. 15, Issue 3, pp. 515-524, (2022) (PubMed).
: "Nanoplasmonic biosensor for rapid detection of multiple viral variants in human serum." dans: Sensors and actuators. B, Chemical, Vol. 365, pp. 131906, (2022) (PubMed).
: "Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron." dans: Vaccines, Vol. 10, Issue 5, (2022) (PubMed).
Pseudonymes pour SARS-CoV-2 Spike Protéines
E2 glycoprotein precursor (S) ProtéinesSurface Glycoprotein (S) Protéines
E2 Protéines
Avez-vous cherché autre chose?
- SARS-CoV-2 Papain-Like Protease Protéines
- SARS-CoV-2 Nucleocapsid Protéines
- SARS-CoV-2 NSP5 (3CL-Pro) Protéines
- SARS-CoV-2 Non-Structural Protein 7 Protéines
- SARS-CoV Spike Protéines
- SARS-Coronavirus Nucleocapsid Protein Protéines
- SARS-Coronavirus Membrane Protein Protéines
- SARNP Protéines
- SARM1 Protéines
- SARDH Protéines
- Sarcolemma Associated Protein Protéines
- Sarcalumenin Protéines
- SAR1B Protéines
- SAR1A Protéines
- SAPS2 Protéines
- SAPS1 Protéines
- SAP30BP Protéines
- SAP30-Like Protéines
- SAP30 Protéines
- SAP18 Protéines
- SARS-CoV-2 Spike S1 Protéines
- SARS-CoV-2 Spike S2 Protéines
- SARS2 Protéines
- SART1 Protéines
- SART3 Protéines
- SASH1 Protéines
- SASH3 Protéines
- SAT1 Protéines
- SAT2 Protéines
- SATB1 Protéines
- SATB2 Protéines
- SAV1 Protéines
- SBDS Protéines
- SBEM Protéines
- SBK1 Protéines
- SBNO1 Protéines
- SC4MOL Protéines
- SC5DL Protéines
- SCAMP1 Protéines
- SCAMP3 Protéines
Vous êtes ici:
